Long-Term Outcome of Pediatric Patients with Anti-NMDA Receptor Encephalitis in a Single Center
Open Access
Abstract
Background: Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is the most common autoimmune encephalitis in children. There is a high probability of recovery if treated promptly. We aimed to analyze the clinical features and long-term outcomes of pediatric patients with anti-NMDA receptor encephalitis. Method: We conducted a retrospective study with definite diagnoses of anti-NMDA receptor encephalitis in 11 children treated in a tertiary referral center between March 2012 and March 2022. Clinical features, ancillary tests, treatment, and outcomes were reviewed. Results: The median age at disease onset was 7.9 years. There were eight females (72.7%) and three males (27.3%). Three (27.3%) patients initially presented with focal and/or generalized seizures and eight (72.7%) with behavioral change. Seven patients (63.6%) revealed normal brain MRI scans. Seven (63.6%) had abnormal EEG results. Ten patients (90.1%) received intravenous immunoglobulin, corticosteroid, and/or plasmapheresis. After a median follow-up duration of 3.5 years, one patient was lost to follow-up at the acute stage, nine (90%) had an mRS ≤ 2, and only one had an mRS of 3. Conclusions: With the early recognition of anti-NMDA receptor encephalitis based on its clinical features and ancillary tests, we were able to treat patients promptly with first-line treatment and achieve favorable neurological outcomes.Keywords
This publication has 32 references indexed in Scilit:
- N-methyl-D-aspartate receptor antibody-mediated neurological disease: results of a UK-based surveillance study in childrenArchives of Disease in Childhood, 2015
- Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS diseaseNeurology, 2014
- Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort studyThe Lancet Neurology, 2013
- Extreme delta brushNeurology, 2012
- Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitisThe Lancet Neurology, 2011
- Update on anti-N-methyl-D-aspartate receptor encephalitis in children and adolescentsCurrent Opinion in Pediatrics, 2010
- Cellular and Synaptic Mechanisms of Anti-NMDA Receptor EncephalitisThe Journal of Neuroscience, 2010
- Anti–N‐methyl‐D‐aspartate receptor (NMDAR) encephalitis in children and adolescentsAnnals of Neurology, 2009
- Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodiesThe Lancet Neurology, 2008
- Interobserver agreement for the assessment of handicap in stroke patients.Stroke, 1988